Article | April 9, 2025

Vial Containment Systems For Gene Therapies: Container Closure Integrity

By Margaret A. Craig, Manager, Scientific Communications, Rui Li, Ph.D., Senior Scientist, R&D, Cryobiology, and T. Page McAndrew, Ph.D., Director, Scientific Communications

GettyImages-1269956871 vial bottle

Maintenance of container closure integrity (CCI) at ultra-low temperature (approx. -80°C) is a necessity for a gene therapy vial containment system. Systems comprising Daikyo Crystal Zenith® cyclic olefin polymer vials and elastomer stoppers with a FluroTec™ barrier film were evaluated over time in a: (a) refrigerator at -80°C, and (b) dry ice container (-78°C). Excellent performance was observed, and no sample was breached.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

West Pharmaceutical Services, Inc.